Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Treatment in Postmenopausal Women: Mechanism of Action
2010-021009-19Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in volumetric BMD of the spine by QCT at 104 weeks. Started Aug 2010; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2010-021009-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021009-19.